Global dysmenorrhea treatment market was worth US$ 560.9 Mn in 2021, according to recent report published by Absolute Markets Insights. The market is expected to expand at a CAGR of 4.8% from 2022 to 2030. Menstrual cycle or ability to give birth to a child, separate women from men. Dysmenorrhea happens to be one such medical disorder related to pain that is caused at the time of monthly periods. There are two basic types of dysmenorrhea – primary and the secondary. While the primary dysmenorrhea is about usual cramps that are seen during the monthly period. Normally these cramps are harmless, and don’t indicate any type of issue. In general circumstances, the pain commences a day or two prior to the period cycle and lasts for nearly 12 to 72 hours. On the other hand, the secondary dysmenorrhea is related to immense pain during the menstrual cycle and lasts for longer period than usual periods. The dysmenorrhea can be treated with the help of the over-the-counter pain relievers, and sometimes a surgery might be needed.

Get PDF sample report with related graphs & charts (Pre & post COVID-19 impact analysis):

The global dysmenorrhea treatment market is growing courtesy of several factors. One such factor is rising level of pollution, especially air pollution. According to a report, it is stated that air pollution is likely to impact or adversely affect the reproductive health of women. Though, the growth of the global dysmenorrhea treatment market is likely to be hindered due to growing concerns about side effects of medications that are being over-the-counter. In the longer run, the global dysmenorrhea treatment market is forecasted to see massive growth courtesy of increasing prescription of multi-vitamins in order to help women strengthen their immune system that constantly takes toll.

View our exclusive press releases on Industry Global News24

Global HIV Diagnostics Market (2022 – 2030)

Global Immunoprecipitation Market (2022 – 2030)

Global Dysmenorrhea Treatment Market Report Highlights

  • The distribution channel segment of the global dysmenorrhea treatment market has been bifurcated into hospitals and clinics, retail stores, gynecologists’ clinics and others. The retail stores segment that accounts for majority of money minted by this market is further bifurcated into online and offline. Specifically, the online segment is growing rampantly as women are still apprehensive about discussing period and period-related medical conditions.
  • The region of Asia Pacific is forecasted to generate revenue at the rapid rate for the global dysmenorrhea treatment market during the forecast period 2022-2030. Developing nations like India are leaving no stones unturned in creating awareness about menstrual health, and rampantly running campaigns for this market. Growing awareness among women and e-commerce market in the continent is helping the market grow.

Speak to our analyst in case of queries before buying this report:

Some of the players operating in the global dysmenorrhea treatment market are:

  • AbbVie Inc.
  • Boehringer Ingelheim Pharma GmbH & Co. KG
  • Daewon Pharmaceutical Co., Ltd
  • Dr. Reddy’s Laboratories Ltd
  • Juniper Pharmaceuticals Inc.
  • Nobelpharma Co., Ltd.
  • Novartis AG
  • PDC Biotech GmbH
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd
  • Vantia Ltd
  • Other Market Participants

Purchase the latest in-depth Global Dysmenorrhea Treatment Market Report @

Global Dysmenorrhea Treatment Market Segmentation

Absolute Markets Insights has segmented into the Global Dysmenorrhea Treatment Market on the basis of type, treatment, distribution channel and region further into countries.

Global Dysmenorrhea Treatment Market Type Outlook (Revenue, USD Million, 2015 – 2030)

  • Primary dysmenorrhea
  • Secondary dysmenorrhea

Global Dysmenorrhea Treatment Market Treatment Outlook (Revenue, USD Million, 2015 – 2030)

  • Pain relievers
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
  • Hormonal birth control
  • Prostaglandin inhibitors
  • Vitamin supplements
  • Surgery
  • Others

Global Dysmenorrhea Treatment Market Distribution Channel Outlook (Revenue, USD Million, 2015 – 2030)

  • Hospitals and Clinics
  • Retail stores
    • Online
    • Offline
  • Gynecologists clinics
  • Others

Global Dysmenorrhea Treatment Market Regional Outlook (Revenue, USD Million, 2015 – 2030)

  • North America (U.S., Canada, Mexico, Rest of North America)
  • Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
  • Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
  • Latin America (Brazil, Argentina, Rest of Latin America)

Top Reports:

Global Osteoporosis Treatment Market –

Global Keyhole Limpet Hemocyanin (KLH) Market –

About Us:

Absolute Markets Insights assists in providing accurate and latest trends related to consumer demand, consumer behavior, sales, and growth opportunities, for the better understanding of the market, thus helping in product designing, featuring, and demanding forecasts. Our experts provide you the end-products that can provide transparency, actionable data, cross-channel deployment program, performance, accurate testing capabilities and the ability to promote ongoing optimization. From the in-depth analysis and segregation, we serve our clients to fulfill their immediate as well as ongoing research requirements. Minute analysis impact large decisions and thereby the source of business intelligence (BI) plays an important role, which keeps us upgraded with current and upcoming market scenarios.

Contact Us:

Contact Name: Shreyas Tanna

Company: Absolute Markets Insights

Email Id:

Phone: IN +91-7400-24-24-24, US +1-510-420-1213


Leave a Reply

Your email address will not be published. Required fields are marked *